Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5001
Assembly Biosciences
ASMB
$410M
| $1.24M | ﹤0.01% |
45,219
+12,164
| +37% | +$331K |
2013 Q2
52 quarters
|
|
5002
Elemental Royalty Corp
ELE
$1.29B
| $1.24M | ﹤0.01% |
71,163
+19,901
| +39% | +$349K |
2025 Q4
2 quarters
|
|
5003
Aura Biosciences
AURA
$639M
| $1.24M | ﹤0.01% |
174,692
-49,349
| -22% | -$353K |
2021 Q4
18 quarters
|
|
5004
BCB Bancorp
BCBP
$252M
| $1.24M | ﹤0.01% |
115,640
-7,238
| -6% | -$73.9K |
2013 Q4
50 quarters
|
|
5005
iPath Select MLP ETN
ATMP
$616M
| $1.24M | ﹤0.01% |
35,840
+252
| +0.7% | +$8.7K |
2023 Q1
13 quarters
|
|
5006
LCNB Corp
LCNB
$271M
| $1.23M | ﹤0.01% |
70,179
+2,566
| +4% | +$42.7K |
2013 Q4
50 quarters
|
|
5007
PIMCO New York Municipal Income Fund II
PNI
$150M
| $1.23M | ﹤0.01% |
173,414
+15,540
| +10% | +$109K |
2026 Q1
1 quarter
|
|
5008
Western Asset High Yield Opportunity Fund Inc
HYI
$124M
| $1.23M | ﹤0.01% |
115,647
-948
| -0.8% | -$10.1K |
2013 Q2
52 quarters
|
|
5009
Anteris Technologies
AVR
$599M
| $1.22M | ﹤0.01% |
124,358
-41,000
| -25% | -$312K |
2025 Q1
5 quarters
|
|
5010
Amerant Bancorp
AMTB
$1.13B
| $1.22M | ﹤0.01% |
47,976
-20,370
| -30% | -$474K |
2019 Q1
29 quarters
|
|
5011
ThredUp
TDUP
$301M
| $1.22M | ﹤0.01% |
178,477
-480,496
| -73% | -$2.25M |
2021 Q1
21 quarters
|
|
5012
Tuniu
TOUR
$53.2M
| $1.22M | ﹤0.01% |
253,077
-154,298
| -38% | -$934K |
2014 Q2
48 quarters
|
|
5013
Schwab International Dividend Equity ETF
SCHY
$2.65B
| $1.22M | ﹤0.01% |
38,520
+3,317
| +9% | +$107K |
2022 Q3
15 quarters
|
|
5014
inTEST
INTT
$166M
| $1.22M | ﹤0.01% |
66,921
+18,696
| +39% | +$317K |
2019 Q2
28 quarters
|
|
5015
DHI Group
DHX
$210M
| $1.21M | ﹤0.01% |
326,494
+139,184
| +74% | +$460K |
2013 Q2
52 quarters
|
|
5016
HMH Holding Inc
HMH
$211M
| $1.21M | ﹤0.01% |
+64,592
| New | +$1.32M |
2026 Q2
0 quarters
|
|
5017
Quad
QUAD
$483M
| $1.2M | ﹤0.01% |
141,958
+1,527
| +1% | +$11.5K |
2013 Q2
52 quarters
|
|
5018
WPP
WPP
$5.9B
| $1.2M | ﹤0.01% |
77,215
+6,062
| +9% | +$108K |
2013 Q2
52 quarters
|
|
5019
OP Bancorp
OPBK
$223M
| $1.19M | ﹤0.01% |
79,658
+36,318
| +84% | +$517K |
2018 Q2
32 quarters
|
|
5020
Dimensional International Small Cap Value ETF
DISV
$5.1B
| $1.19M | ﹤0.01% |
29,613
-919
| -3% | -$38.1K |
2023 Q3
11 quarters
|
|
5021
Odyssey Marine Exploration
OMEX
$37.6M
| $1.18M | ﹤0.01% |
1,382,420
+1,381,327
| +126,379% | +$1.41M |
2013 Q2
52 quarters
|
|
5022
BioVie
BIVI
$9.99M
| $1.17M | ﹤0.01% |
605,471
+530,250
| +705% | +$833K |
2021 Q2
20 quarters
|
|
5023
Stitch Fix
SFIX
$342M
| $1.17M | ﹤0.01% |
285,199
-362,005
| -56% | -$1.32M |
2017 Q4
34 quarters
|
|
5024
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$21.8M
| $1.17M | ﹤0.01% |
49,167
-3,545
| -7% | -$88.1K |
2015 Q1
45 quarters
|
|
5025
Biglari Holdings Class B
BH
$1.37B
| $1.17M | ﹤0.01% |
2,739
-547
| -17% | -$171K |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.